SuperworthZentalis Pharmaceuticals shares outstanding ZNTL
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 71.3M
- On a year earlier
- −0.9%
- fewer shares
Zentalis Pharmaceuticals had 71.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 0.9% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 71.7M | +1% |
| FY2024 | 71.3M | +1% |
| FY2023 | 70.8M | +22% |
| FY2022 | 58.1M | +29% |
| FY2021 | 45M | +13% |
| FY2020 | 39.9M | +615% |
| FY2019 | 5.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 71.3M | −1% | |
| Q1 FY26 | 70.3M | −2% | |
| Q4 FY25 | 71.7M | +1% | |
| Q3 FY25 | 72.1M | +1% | |
| Q2 FY25 | 72M | +1% | |
| Q1 FY25 | 71.7M | +1% | |
| Q4 FY24 | 71.3M | +1% | |
| Q3 FY24 | 71.1M | +1% | |
| Q2 FY24 | 71M | +17% | |
| Q1 FY24 | 71.2M | +20% | |
| Q4 FY23 | 70.8M | +22% | |
| Q3 FY23 | 70.6M | +24% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Zentalis Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.